Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Endogenous glycosaminoglycan that is produced b...
Arylbenzimidazole; CHK2 inhibitor.
HEXIM1 activator.
Oligopeptide found in Actinomycetes; protease i...
EGFR inhibitor.
Vinca alkaloid found in Catharanthus; microtubu...
Serine protease substrate/inhibitor.
Electrophile used in 2’-hydroxyl acylation of...
Non-competitive inhibitor of xanthine oxidase.<...
Side chain commonly attached to taxanes.
Found in Streptomyces; proteasome inhibitor.
α1A-adrenergic antagonist.
p110α PI3K inhibitor.
Lincosamide; peptidyl transferase inhibitor, pr...
PKG inhibitor.
Nucleoside (thymidine) analog; DNA chain termin...
Tretraeptide, binds cell surface integrins.
ALK and IGF-1R inhibitor.
Mycotoxin produced by species of Aspergillus; D...
Tenoxicam impurity